Requires a license holder, subject to chapter 18.130 RCW (the uniform disciplinary act), who performs a stem cell therapy that is not approved by the United States food and drug administration, to: (1) Provide the patient with a written notice informing him or her of the nonapproval before performing the therapy;

(2) Obtain a signed consent form before performing the therapy; and

(3) Include the notice in any advertisements for the therapy.